Is It Too Late to Buy Moderna Stock?
It seems as if nearly everyone is talking about Moderna (NASDAQ: MRNA). The biotech's rapid progress in advancing its COVID-19 vaccine into clinical studies has been impressive. So has its stock performance: Moderna's shares have more than tripled in value so far this year.
After such a massive gain, some investors might be leery of scooping up shares of Moderna now. But is it really too late to buy the biotech stock? I don't think so.
Source Fool.com